公众号 / 文章呼吸衰竭与机械通气消化、代谢与肾脏急症重症综合管理与镇静镇痛

抗击COVID-19:超声是诊断难题中的重要一环吗

Combatting COVID-19: is ultrasound an important piece in the diagnostic puzzle?
PubMed 文献 · Emerg Med J · 2020-09-09
一句话结论作者认为肺超声可在严格框架(教育、质量保证、监督扫描方案)下作为急诊COVID-19诊断的辅助工具,但需警惕锚定偏倚。

当前COVID-19大流行给全球急诊科带来诊断和风险分层困难:分子检测敏感性不足且结果常无法及时用于急诊决策,胸片对COVID-19诊断价值差,CT虽敏感但 impractical 用于所有患者。肺超声(LUS)在急性呼吸衰竭评估中已有确立角色,疫情期间被用作决策支持工具;LUS在病毒性肺炎中显示特征性改变,虽非COVID-19特异,但可作为诊断过程的辅助。本综述旨在提供LUS适应症指导、描述COVID-19典型超声异常、提供在COVID-19患者中执行LUS及管理感染控制风险的建议,并强调大流行期间锚定偏倚风险和考虑替代病理的必要性。

要点

  • 分子检测敏感性不足且结果常无法及时用于急诊决策,胸片对COVID-19诊断价值差,CT虽敏感但难以用于所有患者。
  • LUS在病毒性肺炎中显示特征性改变,虽非COVID-19特异,但作者认为可帮助减轻未分化呼吸道症状患者的不确定性。
  • LUS操作快速、可重复且可在床旁完成,疫情期间被用作决策支持工具。
  • 作者强调大流行期间需警惕锚定偏倚,并考虑替代病理。
  • 作者认为LUS可在严格框架(教育、质量保证、监督扫描方案)下作为急诊COVID-19的床旁检测工具。

适用人群与场景

  • 急诊科未分化的呼吸道症状患者。

红旗征与不能漏的情况

  • 大流行期间需警惕锚定偏倚,并考虑替代病理。

研究设计与关键结果

  • 本综述旨在提供LUS适应症指导、描述COVID-19典型超声异常、提供在COVID-19患者中执行LUS及管理感染控制风险的建议。
  • LUS在病毒性肺炎中显示特征性改变,但这些改变对COVID-19不具特异性。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为LUS可帮助减轻未分化呼吸道症状患者的不确定性。
  • 作者认为LUS可在严格框架(教育、质量保证、监督扫描方案)下作为急诊COVID-19的床旁检测工具。
  • 作者强调大流行期间需警惕锚定偏倚并考虑替代病理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The current COVID-19 pandemic is causing diagnostic and risk stratification difficulties in Emergency Departments (ED) worldwide. Molecular tests are not sufficiently sensitive, and results are usually not available in time for decision making in the ED. Chest x-ray (CXR) is a poor diagnostic test for COVID-19, and computed tomography (CT), while sensitive, is impractical as a diagnostic test for all patients. Lung ultrasound (LUS) has an established role in the evaluation of acute respiratory failure and has been used during the COVID-19 outbreak as a decision support tool. LUS shows characteristic changes in viral pneumonitis, and while these changes are not specific for COVID-19, it may be a useful adjunct during the diagnostic process. It is quick to perform and repeat and may be done at the bedside. The authors believe that LUS can help to mitigate uncertainty in undifferentiated patients with respiratory symptoms. This review aims to provide guidance regarding indications for LUS, describe the typical sonographic abnormalities seen in patients with COVID-19 and provide recommendations around the logistics of performing LUS on patients with COVID-19 and managing the infection control risk of the procedure. The risk of anchoring bias during a pandemic and the need to consider alternative pathologies are emphasised throughout this review. LUS may be a useful point-of-care test for emergency care providers during the current COVID-19 pandemic if used within a strict framework that governs education, quality assurance and proctored scanning protocols.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. McDermott C, Daly J, Carley S, et al. Combatting COVID-19: is ultrasound an important piece in the diagnostic puzzle? Emerg Med J. 2020. PMID: 32907844. doi:10.1136/emermed-2020-209721

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。